Skip to content

Clinical Study for treatment of Eye infection

Rose Bengal Electromagnetic Activation with Green light for Infection Reduction Study (REAGIR Study) - REAGIR Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/028942
Enrollment
330
Registered
2020-11-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H160- Corneal ulcer

Interventions

Intervention1: Corneal Collagen cross linking using Rose Bengal Dye and Green light: Single treatment of Corneal Collagen cross linking using Rose Bengal Dye and Green light, along with the Standard t

Sponsors

The National Eye Institute at the National Institute of Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Presence of smear or culture positive fungal or acanthamoeba ulcer OR 2) Presence of smear and culture negative ulcer 3) Visual Acuity worse than 20/40 4) Willingness to participate

Exclusion criteria

Exclusion criteria: 1) Evidence of herpetic keratitis 2) Impending of frank corneal perforation 3) History of recent intraocular surgery 4) Fellow eye visual acuity 5) Inability to understand and participate with the study

Design outcomes

Primary

MeasureTime frame
Best corrected Visual AcuityTimepoint: 6 months

Secondary

MeasureTime frame
1. Best corrected Visual Acuity at 12 months 2. Adverse events needing TPK 3. Microbiological cure on day-2 repeat smear and culture 4. Infiltrate/scar measurement 5. Change in Visual Function Questionnaire from baseline to 6 months 6. Pain scale at baseline at day 1 and 3Timepoint: 12 months

Countries

India, United States of America

Contacts

Public ContactDr N Venkatesh Prajna

Aravind Eye Hospital and Postgraduate Institute of Ophthalmology

prajna@aravind.org914524356100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026